| Product Code: ETC7052899 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Egypt Patented Drugs Market Overview |
3.1 Egypt Country Macro Economic Indicators |
3.2 Egypt Patented Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Egypt Patented Drugs Market - Industry Life Cycle |
3.4 Egypt Patented Drugs Market - Porter's Five Forces |
3.5 Egypt Patented Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.6 Egypt Patented Drugs Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
3.7 Egypt Patented Drugs Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 Egypt Patented Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing investments in research and development (RD) for new patented drugs |
4.2.2 Growing prevalence of chronic diseases and the need for innovative treatment options |
4.2.3 Favorable government regulations and policies supporting patent protection and innovation in the pharmaceutical industry |
4.3 Market Restraints |
4.3.1 High costs associated with developing patented drugs and obtaining regulatory approvals |
4.3.2 Competition from generic drug manufacturers impacting pricing and market share |
4.3.3 Stringent regulatory requirements and lengthy approval processes for patented drugs |
5 Egypt Patented Drugs Market Trends |
6 Egypt Patented Drugs Market, By Types |
6.1 Egypt Patented Drugs Market, By Distribution Channel |
6.1.1 Overview and Analysis |
6.1.2 Egypt Patented Drugs Market Revenues & Volume, By Distribution Channel, 2021- 2031F |
6.1.3 Egypt Patented Drugs Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.1.4 Egypt Patented Drugs Market Revenues & Volume, By Drug Store and Retail Pharmacies, 2021- 2031F |
6.1.5 Egypt Patented Drugs Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.2 Egypt Patented Drugs Market, By Dosage Form |
6.2.1 Overview and Analysis |
6.2.2 Egypt Patented Drugs Market Revenues & Volume, By Solid Drug Product, 2021- 2031F |
6.2.3 Egypt Patented Drugs Market Revenues & Volume, By Liquid Drug Product, 2021- 2031F |
6.2.4 Egypt Patented Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Egypt Patented Drugs Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 Egypt Patented Drugs Market Revenues & Volume, By Cardiovascular Diseases, 2021- 2031F |
6.3.3 Egypt Patented Drugs Market Revenues & Volume, By Cancer, 2021- 2031F |
6.3.4 Egypt Patented Drugs Market Revenues & Volume, By Autoimmune Diseases, 2021- 2031F |
6.3.5 Egypt Patented Drugs Market Revenues & Volume, By Others, 2021- 2031F |
7 Egypt Patented Drugs Market Import-Export Trade Statistics |
7.1 Egypt Patented Drugs Market Export to Major Countries |
7.2 Egypt Patented Drugs Market Imports from Major Countries |
8 Egypt Patented Drugs Market Key Performance Indicators |
8.1 Number of new patents granted for pharmaceutical products in Egypt |
8.2 Research and development expenditure as a percentage of total revenue for pharmaceutical companies in Egypt |
8.3 Adoption rate of newly launched patented drugs in the Egyptian market |
9 Egypt Patented Drugs Market - Opportunity Assessment |
9.1 Egypt Patented Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.2 Egypt Patented Drugs Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
9.3 Egypt Patented Drugs Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 Egypt Patented Drugs Market - Competitive Landscape |
10.1 Egypt Patented Drugs Market Revenue Share, By Companies, 2024 |
10.2 Egypt Patented Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here